Radius Health, Inc. Profile Avatar - Palmy Investing

Radius Health, Inc.

Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopa…

Drug Manufacturers - Specialty & Generic
US, Waltham [HQ]

Ratios

15 Records · Starting from 2009
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
- - - - - - - - - - - - - - - - 93.98 91.51 90.72 12.18 16.43 14.00 10.68
Profit Margin
- - - - - - - - - - - - - - - - - - - - - - - - - - 4.84 -0.89
Operating Margin
- - - - - - - - - - - - - - - - -1,125.96 -205.63 -64.75 0.40 7.75 6.48 -0.14
EPS Growth
- - - - - - - - - - - - - - - - - - - - - - - - - - 1.86 -115.31
Return on Assets (ROA)
- - - - - - - - - - - - - - - - - - - - - - - - - - 9.24 -1.50
Return on Equity (ROE)
- - - - - - - - - - - - - - - - - - - - - - - - - - 17.69 -2.84
Return on Invested Capital (ROIC)
- - - - - - - - - - - - - - - - - - - - - - - - - - 13.53 -0.28
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
- - - - - - - - - - - - - - - - - - - - - - - - - - 20.36 21.29
Debt/Equity
- - - - - - - - - - - - - - - - - - - - - - - - - - 38.98 40.23
Debt/EBITDA
- - - - - - - - - - - - - - - - - - - - - - - - - - 144.61 937.83
Debt/Capitalization
- - - - - - - - - - - - - - - - - - - - - - - - - - 28.05 28.69
Interest Debt per Share USD
- - - - - - - - - - - - - - - - - - - - - - - - - - 13.55 13.71
Debt Growth
- - - - - - - - - - - - - - - - - - - - - - - - - - 77.48 -1.76
Liquidity
Current Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - 175.95 169.89
Quick Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - 93.35 83.88
Cash Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - 11.48 1.86
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
- - - - - - - - - - - - - - - - - - - - - - - - - - 951.09 923.95
Receivables Turnover
- - - - - - - - - - - - - - - - - - - - - - - - - - 1,466.76 1,369.61
Payables Turnover
- - - - - - - - - - - - - - - - - - - - - - - - - - 1,377.08 1,229.34
Asset Turnover
- - - - - - - - - - - - - - - - - - - - - - - - - - 190.84 167.97
Coverage
Interest Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - 2,645.89 -21.11
Asset Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - 300 300
Cash Flow Coverage (CFGR)
- - - - - - - - - - - - - - - - - - - - - - - - - - 63.91 38.15
EBITDA Coverage
- - - - -5,400 -2,400 -2,300 -2,400 -5,200 - - -2,900 -800 -400 200 4,000 2,600 200
Dividend Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - -700 100
Time Interest Earned (TIE)
- - - - - - - - - - - - - - - - - - - - - - 100 100 100 100
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - 2.29 2.28
Earnings Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - 18.19 -2.77
Price/Earnings (P/E)
- - - - - - - - - - - - - - - - - - - - - - - - - - 5.4970 -36.0539
Price/Book (P/B)
- - - - - - - - - - - - - - - - - - - - - - - - - - 97.27 102.39
Price/Sales (P/S)
- - - - - - - - - - - - - - - - - - - - - - - - - - 26.62 32.26
Price/Cash Flow (P/CF)
- - - - - - - - - - - - - - - - - - - - - - - - - - 390.40 667.23
End of RDUS's Analysis
CIK: 1428522 CUSIP: 750469207 ISIN: US7504692077 LEI: - UEI: -
Secondary Listings
RDUS has no secondary listings inside our databases.